Global Capsule Endoscopy Market

Capsule Endoscopy Market Size, Share, Growth Analysis, By Product(Capsule Endoscope, Work Stations & Recorders), By Application(Small Intestine Disorder, Esophageal Disorder, Colonic Disorder), By End User(Hospitals, Diagnostic Laboratories, Specialty Clinics), By Region - Industry Forecast 2024-2031


Report ID: SQSG35A2027 | Region: Global | Published Date: February, 2024
Pages: 165 | Tables: 89 | Figures: 76

Capsule Endoscopy Market Dynamics

Capsule Endoscopy Market Driver

  • The global market for capsule endoscopy is projected to be driven by the increasing technical developments in endoscopic treatments.

The range of applications for capsule endoscopy systems, including those for colon disease, small bowel disease, and esophageal illness, has increased due to technological developments. Technological advancements have enhanced the traditional endoscopy's diagnostic, monitoring, and viewing capabilities. New varieties of capsule endoscopes, including those for the small intestine, colon, and oesophagus, have been developed as a result of advanced technologies. Product manufacturers are also developing user-friendly and high-resolution cameras with a 360-degree panoramic view. Endoscopy now has a high level of accuracy, safety, and precision thanks to advancements that would have been difficult to attain only a few years ago. The video scope and the capsule endoscope have replaced the fibreoptic endoscope (fiberscope) period recently. Also, in November, 2021, PillCam Small Bowel 3 system for remote endoscopy procedures. With the use of Amazon logistics and Medtronic's PillCam technology, the PillCam SB3 @HOME programme aims to give patients access to rapid, reliable results from the convenience of their own homes. The telehealth option PillCam SB3 @HOME allows for direct vision and monitoring of the small bowel. It can assist in identifying lesions that are missed by upper and lower endoscopy and may: indicate Crohn's disease, find hidden bleeding, or reveal the causes of iron deficiency anaemia (IDA).

Capsule Endoscopy Market Restraint

  • Limitations related to the application of capsule endoscopy are projected to restrain market expansion.

The market expansion of capsule endoscopy is hampered by some of its limitations, such as capsule retention and utilisation restricted to diagnostic purposes. Endoscopic retrieval or surgical excision may be necessary to reduce the chance of capsule retention. For instance, a study published in Annals of Translational Medicine found that about 2% of patients undergoing a small bowel capsule endoscopic surgery had capsule retention. This makes the use of capsule endoscopes difficult. Also, problems in some sections of the intestine are ignored due to the capsule's fast transit and blurry, unreadable images. Images may be distorted by food or stool residue. The main danger of capsule endoscopy is small bowel device retention. Patients who undergo the test to check for bleeding run a very low risk—between one and two percent—of bleeding. Patients with Crohn's disease may see a four to five percent increase in risk. However, it is projected that the retention rate would decrease with technology developments and better designed wireless capsules, which will spur the capsule endoscopy market expansion.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Capsule Endoscopy Market size was valued at USD 799.36 million in 2019 and is poised to grow from USD 898.48 million in 2023 to USD 2,288.95 million  by 2031, growing at a CAGR of 12.4% in the forecast period (2024-2031).

Due to the increasing demand for capsule-based endoscopes and endoscopic systems for various screening and diagnostic procedures, there is intense competition among the existing providers. The rivalry is also growing as a result of technological developments made in the field of endoscopy by important players. Prominent market players are taking steps to grow their R&D in the field of capsule-based endoscopic technologies, as well as strategic alliances with other market competitors through mergers and acquisitions, product launches, collaborations, and other activities. IntroMedic Co., Ltd., Olympus Corporation, Chongqing Jinshan Science & Technology (Group) Co., Ltd., RF System lab, and CapsoVision are a few of the key players in the capsule endoscopy market. 'Medtronic', 'Olympus Corporation', 'IntroMedic Co., Ltd.', 'Fujifilm Holding Corporation', 'CapsoVision, Inc.', 'RF System lab', 'Given Imaging Ltd. (A subsidiary of Medtronic)', 'Chongqing Jinshan Science & Technology (Group) Co., Ltd.', 'Intromedic', 'RF System Lab', 'Check-Cap', 'Medisafe Distribution Inc.', 'Jinshan Science & Technology Group Co., Ltd.', 'CapsoVision', 'Covidien Ltd.', 'Stryker Corporation', 'EndoChoice, Inc.', 'Boston Scientific Corporation', 'Pentax Medical (Hoya Corporation)', 'SMART Medical Systems Ltd.'

The global market for capsule endoscopy is projected to be driven by the increasing technical developments in endoscopic treatments.

Increase in Gastrointestinal Disorders Worldwide to Drive Global Capsule Endoscopy Market Growth - Due to a variety of environmental factors as well as a shift in people's overall lifestyles, medical illnesses such gastrointestinal disorders, inflammatory bowel diseases, and colorectal cancer have developed dramatically in recent years. Globally, the number of cases of colorectal cancer is rising. The second most prevalent disease to cause death and the third most frequently diagnosed cancer is colorectal cancer. The death rate linked to colorectal cancer can be significantly decreased by screening and increased awareness. Additionally, GI problems like CRC, inflammatory bowel disease, and appendicitis are more likely to develop as people age; for this reason, screening is crucial to prevent complications and further development of GI disorders. According to the National Colorectal Round Table, screening at age of 50 can prevent 230,000 deaths from colorectal cancer. The need for capsule endoscopy is predicted to rise significantly in the upcoming years due to the rise in these medical disorders. The standard procedure for detecting colorectal cancer is a colonoscopy. However, capsule endoscopy is being used more frequently as a result of the limitations of colonoscopy and the rising need for minimally invasive procedures. A non-invasive wireless diagnostic technique called capsule endoscopy gives doctors a thorough view of the small intestine. The use of technology has completely changed how small intestine problems like cancer, inflammatory bowel disease, celiac disease, and mysterious gastrointestinal bleeding are diagnosed and treated.

North America region is expected to hold the largest market share in the global capsule endoscopy market

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Capsule Endoscopy Market

Report ID: SQSG35A2027

$5,300
BUY NOW GET FREE SAMPLE